INTERLEUKIN 4 (IL-4)
白细胞介素 4 (IL-4)
基本信息
- 批准号:6098948
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Interleukin-4 (IL-4) is a multifunctional type I
cytokine. Among its most important functions are determining the
production of certain immunoglobulin classes, particularly IgE
through the regulation of immunoglobulin class switching, and the
determination of the differentiation of na?ve CD4+ T cells into TH2
cells. The work covered under this project has been concerned with
key biologic functions of IL-4, the means through which IL-4
producing cells appear, and the molecular basis through which IL-4
signaling is accomplished. The IL-4 receptor (R) is a heterodimer
consisting of the IL-4 Ra chain and the gc chain. Distinct domains
of the receptor largely control IL-4 mediated growth and gene
activation. Growth depends upon an IL-4Ra domain centering on
Y497; phosphorylated Y497 acts as a docking site for a series of
PTB-domain-containing proteins including IRS-1, IRS-2, Shc, and
FRIP, a newly identified IL-4 receptor interacting protein. IRS-1,
IRS-2 and Shc mediate their function by acting as adapter
molecules that recruit pathways leading to growth and resistance to
apoptosis. FRIP is a PTB-domain containing protein that appears to
inhibit the RAS pathway through it capacity to bind to RAS-GAP
and to recruit it to the vicinity of activated RAS. FRIP has recently
been shown to be phosphorylated in response to IL-2 , IL-3 and
insulin. It is also phosphorylated in response to T cell receptor
engagement, although it is not established whether this is direct or
indirect. FRIP is hyperphosphorylated in anergic AE7 cells and, in
its ability to block the RAS pathway, may play a role in induction or
maintenance of the anergic state. IL-4-mediated gene activation and
differentiation, such as immunoglobulin class switching and
development of na?ve T cells into TH2 cells depend upon the
activation of Stat6; such activation is controlled by a more distal
portion of the IL-4 Ra chain containing three tyrosines, each one of
which, when phosphorylated, appears to be a Stat-6 binding site.
These Stat6 sites can be moved to another part of the receptor
where they continue to mediate their function of inducing
IL-4-specific gene activation. Recent studies indicate that the level
of expression of IL-4Ra chain is controlled by a process of
phosphorylation/ dephosphorylation. Indeed, mice lacking the
phosphatase SHP-1 are defective in IL-4 Ra expression, presumably
because of tonic phosphorylation of key tyrosines in the receptor
cytosolic domain. Development of naive T cells into
IL-4-producing cells is dependent upon IL-4 itself. IL-4Ra chain
knockout mice display a major impairment in the development of
TH2-type immune responses in response to infection with
Nippostrongylus brasiliensis. There does appear to be a potential
pathway of development of TH2 cells independent of IL-4 (or
IL-13) and of Stat6. It is revealed by the study of BCL6 knockout
mice, which develop a severe cardiac and lung inflammatory disease
characterized by the production of TH2 cytokines. BCL6 is a
transcriptional repressor that interacts with genetic elements similar
to those recognized by Stat6 and thus potentially inhibits Stat6; in
the absence of BCL6 , TH2 differentiation may occur
spontaneously. Indeed, mice that are knockouts for both BCL6 and
Stat6 or BCL6 and IL-4 continue to develop the TH2-based
inflammatory responses although their peripheral T cells continue to
require IL-4 in order to develop into TH2 cells. The development
of naive TH precursor cells into TH1 and TH2 cells is a highly
regulated process, with the acquisition of IL-4 and IFNg-producing
activities being independently controlled. Fully differentiated TH1
cells fail to acquire IL-4-producing capacity even when cultured
with antigen in the presence of IL- 4. It has now been shown that
fully differentiated TH1 cells display a desensitized IL-4R. IL-4 fails
to elicit STAT-6 phosphorylation in such cells. Interestingly, these
cells also are deficient in IRS-2, as are cells of STAT-6 KO mice
that have been stimulated in vitro in with IL-4. Thus, the induction
of the major growth regulatory substrate phosphorylated in
response to IL-4 is under the control of STAT-6, explaining how
the gene activation function of the IL-4 receptor plays a role in
controlling growth. These experiments provide a framework in
which to understand the mechanisms through which IL-4
determines the biologic characteristics of immune responses and to
identify biochemical steps in its function that may be suitable for the
development of antagonists of agonists that could aid in the
development of drugs for a variety of allergic, autoimmune,
infectious and inflammatory diseases.
白介素 4 (IL-4) 是一种多功能 I 型
细胞因子。其最重要的功能之一是确定
生产某些免疫球蛋白类别,特别是 IgE
通过调节免疫球蛋白类别转换,以及
确定幼稚 CD4+ T 细胞分化为 TH2
细胞。该项目涵盖的工作涉及
IL-4 的关键生物学功能,IL-4 发挥作用的途径
产生细胞的出现,以及 IL-4 产生的分子基础
信令完成。 IL-4 受体 (R) 是异二聚体
由 IL-4 Ra 链和 gc 链组成。不同的领域
受体的变化很大程度上控制 IL-4 介导的生长和基因
激活。生长依赖于以 IL-4Ra 结构域为中心的结构域
Y497;磷酸化的 Y497 充当一系列的对接位点
含有 PTB 结构域的蛋白质,包括 IRS-1、IRS-2、Shc 和
FRIP,一种新发现的 IL-4 受体相互作用蛋白。国税局-1,
IRS-2 和 Shc 通过充当适配器来调节其功能
招募导致生长和抵抗的途径的分子
细胞凋亡。 FRIP 是一种含有 PTB 结构域的蛋白质,似乎
通过与 RAS-GAP 结合的能力抑制 RAS 通路
并将其招募到激活的 RAS 附近。 FRIP 最近
研究表明,IL-2、IL-3 和 IL-2 会导致磷酸化
胰岛素。它还响应 T 细胞受体而被磷酸化
参与,尽管尚不清楚这是直接参与还是
间接。 FRIP 在无反应性 AE7 细胞中过度磷酸化,并且在
它阻断 RAS 途径的能力,可能在诱导或
维持无反应状态。 IL-4介导的基因激活和
分化,例如免疫球蛋白类别转换和
幼稚 T 细胞发育为 TH2 细胞取决于
激活Stat6;这种激活是由更远端的控制的
IL-4 Ra链的一部分含有三个酪氨酸,每个酪氨酸为
当磷酸化时,它似乎是 Stat-6 结合位点。
这些 Stat6 位点可以移动到受体的另一部分
他们继续发挥诱导功能
IL-4 特异性基因激活。最近的研究表明,水平
IL-4Ra链的表达受以下过程控制
磷酸化/去磷酸化。事实上,小鼠缺乏
据推测,磷酸酶 SHP-1 在 IL-4 Ra 表达中存在缺陷
由于受体中关键酪氨酸的强直性磷酸化
胞质结构域。幼稚 T 细胞发育成
IL-4 产生细胞依赖于 IL-4 本身。 IL-4Ra链
基因敲除小鼠的发育受到严重损害
TH2型免疫反应对感染的反应
巴西圆线虫。似乎确实有潜力
TH2细胞的发育途径不依赖于IL-4(或
IL-13) 和 Stat6。 BCL6敲除研究揭示
小鼠,出现严重的心脏和肺部炎症疾病
其特点是产生 TH2 细胞因子。 BCL6 是
与类似遗传元件相互作用的转录抑制因子
那些被 Stat6 识别并因此可能抑制 Stat6 的物质;在
BCL6缺失,TH2分化可能发生
自发地。事实上,同时敲除 BCL6 和
Stat6或BCL6和IL-4继续开发基于TH2的
尽管它们的外周T细胞继续发生炎症反应
需要IL-4才能发育成TH2细胞。发展历程
将初始 TH 前体细胞转化为 TH1 和 TH2 细胞是一个高度
调节过程,获得产生 IL-4 和 IFNg 的
活动受到独立控制。全差异化TH1
即使在培养时,细胞也无法获得产生 IL-4 的能力
在 IL-4 存在的情况下与抗原结合。现在已经表明
完全分化的 TH1 细胞显示出脱敏的 IL-4R。 IL-4失败
引发此类细胞中的 STAT-6 磷酸化。有趣的是,这些
细胞也缺乏 IRS-2,STAT-6 KO 小鼠的细胞也是如此
已在体外用 IL-4 刺激。因此,归纳
主要生长调节底物磷酸化
对 IL-4 的反应受到 STAT-6 的控制,解释了如何
IL-4受体的基因激活功能在
控制增长。这些实验提供了一个框架
了解 IL-4 的机制
决定免疫反应的生物学特征并
确定其功能中可能适合的生化步骤
开发激动剂的拮抗剂,有助于
开发针对多种过敏、自身免疫、
传染性和炎症性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Paul其他文献
William Paul的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Paul', 18)}}的其他基金
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
通过 RNAi 分析细胞因子和 TCR 介导的淋巴细胞反应
- 批准号:
7592323 - 财政年份:
- 资助金额:
-- - 项目类别:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
通过 RNAi 分析细胞因子和 TCR 介导的淋巴细胞反应
- 批准号:
8745429 - 财政年份:
- 资助金额:
-- - 项目类别:
Analyzing Cytokine- and TCR-Mediated Lymphocyte Responses by RNAi
通过 RNAi 分析细胞因子和 TCR 介导的淋巴细胞反应
- 批准号:
8555902 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual